Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 9476Triple Negative Breast Neoplasms 635Neoplasms 413Lung Neoplasms 342Prostatic Neoplasms 321Ovarian Neoplasms 299Colorectal Neoplasms 289Neoplasm Metastasis 280Motor Activity 267Carcinoma, Intraductal, Noninfiltrating 231Colonic Neoplasms 193Breast Neoplasms, Male 172Lymphedema 170Melanoma 158Pancreatic Neoplasms 152Breast Carcinoma In Situ 151Carcinoma, Non-Small-Cell Lung 149Uterine Cervical Neoplasms 144Fatigue 140Head and Neck Neoplasms 132Pain 122Breast Cancer Female 122Brain Neoplasms 118Stomach Neoplasms 117Sarcoma 106Depression 105Breast Cancer Lymphedema 101Anxiety Disorders 101Lymphoma 96Cardiotoxicity 89

Interventions

Tamoxifen 2palbociclib 1exemestane 1elacestrant 1Letrozole 1Fulvestrant 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × ER+ Breast Cancer × Breast × Clear all
NCT06923527 2026-05-12

Circulating Tumor DNA

Yale University

Phase 2 Recruiting
50 enrolled
Breast

ER+ Breast Cancer

NCT04985266 2024-12-05

TRAK-ER

Royal Marsden NHS Foundation Trust

Phase 2 Recruiting
1,100 enrolled
Breast

ER+ Breast Cancer

NCT04824014 2024-02-06

4FMFES-PET Imaging of ER+ Advanced Breast Cancers

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Phase 2 Unknown
150 enrolled
Breast

ER+ Breast Cancer

NCT05525481 2023-11-01

PREDICTAM

Erasmus Medical Center

Phase 4 Unknown
100 enrolled
Breast

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡